ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Roundup herbicide risk rises for Bayer

by Marc S. Reisch
August 3, 2019 | APPEARED IN VOLUME 97, ISSUE 31

 

Bayer faces lawsuits from 18,400 plaintiffs claiming that glyphosate, the active ingredient in the herbicide Roundup, made them ill. The tally, revealed in the firm’s second-quarter earnings report, is an increase of 5,000 claimants from 3 months ago. In the three cases that have gone to trial since last June, when Bayer bought Monsanto and inherited the Roundup claims, juries have ordered millions of dollars in payouts. But judges in each case later significantly cut awards. In the most recent instance, a California state court judge reduced an award of more than $2 billion to $87 million. The next case goes to trial in Missouri later this month.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment